Results 201 to 210 of about 270,121 (304)

Fibrinogen Changes Before and After Intravenous Thrombolysis as Predictors of Cerebral Injury and Clinical Outcomes in Acute Ischemic Stroke: A Multicenter Prospective Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Plasma fibrinogen is essential in thrombosis and fibrinolysis, yet its dynamic changes pre‐ and post‐intravenous thrombolysis (IVT) for predicting brain injury severity and prognosis in acute ischemic stroke (AIS) patients remain unclear.
Wenhai Zhai, Yang Qu, Reziya Abuduxukuer, Kejia Zhang, Peng Zhang, Xin Tang, Huaimei Zhang, Lijuan Wang, Lichong Yang, Shuangxu Tan, Zhimei Yuan, Ce Han, Lili He, Yuping Zheng, Fenglan Zhao, Lijie Guo, Ligang Jiang, Jinfeng Li, Yongfei Jiang, Xuexia Zou, Dan Xu, Han Xu, Xiaojia Wang, Yingbin Qi, Xuefeng Hu, Yu Zhang, Zhen‐Ni Guo, Hang Jin, on behalf of the Biomarkers of Brain Injury Investigator Study Group   +28 more
wiley   +1 more source

Integration of physiological and remote sensing traits for improved genomic prediction of wheat yield. [PDF]

Plant Genome
García-Barrios G, Robles-Zazueta CA, Montesinos-López A, Montesinos-López OA, Reynolds MP, Dreisigacker S, Carrillo-Salazar JA, Acevedo-Siaca LG, Guerra-Lugo M, Thompson G, Pecina-Martínez JA, Crossa J.   +11 more
europepmc   +1 more source

Defensa de la vida física del paciente en estado terminal : entre la dignidad y la autonomía

, 2014
Resumen: Proponemos un análisis crítico de los fundamentos que sustentan la llamada “Ley de Muerte Digna” incorporada en la Ley que consagra la regulación de los derechos del paciente, historia clínica, consentimiento informado, (Art. 2º, inc. “e” párr.
openaire   +1 more source

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer, Frauke Stascheit, Maximilian Mönch, Paolo Doksani, Carla Dusemund, Meret Herdick, Philipp Mergenthaler, Maike Stein, Amani Suboh, Jutta Schröder‐Braunstein, Guido Wabnitz, Jan D. Lünemann, Sophie Lehnerer, Sarah Hoffmann, Andreas Meisel   +14 more
wiley   +1 more source

From Traditional Use to Molecular Mechanisms: A Bioinformatic and Pharmacological Review of the Genus <i>Kalanchoe</i> with In Silico Evidence. [PDF]

BioTech (Basel)
Delgado-González CR, Sharma A, Islas-Pelcastre M, Saucedo-García M, Aquino-Torres E, Pacheco-Trejo J, Armenta-Jaime S, Rivero-Pérez N, Madariaga-Navarrete A.   +8 more
europepmc   +1 more source

Olink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti‐AChR Antibody‐Positive Myasthenia Gravis: FGF‐19 as a Novel Biomarker

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to systematically observe the clinical manifestations, immune cell subsets, and dynamic changes in serological indicators in patients with myasthenia gravis (MG) before and after efgartigimod (EFG) treatment. Methods We analyzed the baseline data, laboratory parameters, and lymphocyte subset proportions in MG ...
Tiancheng Luo, Deyou Peng, Zhouao Zhang, Mingjin Yang, Xinyan Guo, Tianyu Ma, Xiaoyu Huang, Mingming Xu, Linlin Fu, Yong Zhang   +9 more
wiley   +1 more source

Crystallographic Structure of Human Dihydroorotate Dehydrogenase in Complex with the Natural Product Inhibitor Lapachol. [PDF]

ACS Omega
Purificação AD, Benz LS, Lima Silva WJ, Emery FS, Andrade CH, Weiss MS, Nonato MC.   +6 more
europepmc   +1 more source

Valoración del estado nutricional del paciente con enfemedad renal terminal en tratamiento renal sustitutivo con diálisis peritoneal

, 2018
Treball Final de Grau en Medicina. Codi: MD1158. Curs acadèmic: 2017/2018 Introduction: Nutritional disorders associated with chronic renal failure have enormous repercussions on morbidity an d mortality of patients . At the beginning of peritoneal dialysis the uremic symptomatology decreases, but malnutrition can be
openaire  

Daratumumab Treatment for Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): A Case Report

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune‐mediated neuropathy featuring progressive weakness, sensory deficits, and areflexia. While corticosteroids, intravenous immunoglobulin, and plasmapheresis are effective first‐line immunotherapies, a subset of patients remains treatment‐refractory.
Xueyu Zhang, Jianli Zhao, Xue Zhao, Xiaowei Hu, Zichun Xiao, Jie Wu, Xiaowen Li, Jing Xu, Yu‐Jing Li   +8 more
wiley   +1 more source

HLA-B Serine 116 Confers Protection Against Severe COVID-19 in a Cohort From Rio de Janeiro, Brazil. [PDF]

HLA
Pereira MADS, Ferreira SN, Gonçalves CCA, Reis MCD, Zampier CDP, Leitão IC, Lopes MSA, Rossi AD, Soares-Lima SC, Galliez RM, Barroso SPC, Junior ODCF, Tanuri A, Castiñeiras TMPP, Rossi ÁD, Cardoso CC.   +15 more
europepmc   +1 more source